A major risk factor for the development of Alzheimer's disease (AD) is increasing age, but the reason behind this association has not been identified. It is thought that the changes in endocytosis seen in AD patients are causal for this condition. Thus, we hypothesized that the increased risk of developing AD associated with ageing may be because of changes in endocytosis. We investigated using Western blotting whether the expression of endocytic proteins involved in clathrin-mediated and clathrin-independent endocytosis are altered by increasing age in a mouse model of amyloid pathology. We used mice transgenic for human amyloid precursor protein containing the V717I London mutation. We compared the London mutation mice with age-matched wild-type (WT) controls at three ages, 3, 9 and 18 months, representing different stages in the development of pathology in this model. Having verified that the London mutation mice overexpressed amyloid precursor protein and β-amyloid, we found that the expression of the smallest isoform of PICALM, a key protein involved in the regulation of clathrin-coated pit formation, was significantly increased in WT mice, but decreased in the London mutation mice with age. PICALM levels in WT 18-month mice and clathrin levels in WT 9-month mice were significantly higher than those in the London mutation mice of the same ages. The expression of caveolin-1, involved in clathrin-independent endocytosis, was significantly increased with age in all mice. Our results suggest that endocytic processes could be altered by the ageing process and such changes could partly explain the association between ageing and AD. NeuroReport 28:963-968
Introduction
Dementia currently affects about 47.5 million people worldwide [1] with Alzheimer's disease (AD) being the most common cause [1, 2] . The major risk factor for developing AD is increasing age, with about 11% of people aged 65 years and over having the disease, rising to 32% over the age of 85 years [2] . It is estimated that by 2050 there will be over 115 million people in the world with AD [3] . However, few studies have considered how ageing may contribute to the aetiology of the disease.
Alterations in endocytosis represent a potential mechanism that could underlie the association of AD with age. Changes in endocytosis were first identified in cases of AD 20 years ago [4] . Since 2009, a number of Genome Wide Association Studies have described polymorphisms in genes associated with a small increased risk of developing AD and at least three of the proteins encoded by these genes, PICALM, BIN-1 and SORL1, are involved in endocytosis [5] , emphasising the importance of this pathway in AD. Amyloid precursor protein (APP), the source of β-amyloid (Aβ), a key protein involved in the pathology of AD, is transported by the secretory pathway to the cell surface and is then internalized by endocytosis. Most amyloidogenic processing occurs only after this event, within the endocytic/lysosomal system [6, 7] . Endocytosis is thus central to the production of Aβ. models of amyloid pathology. Early endocytic changes, as evidenced by an increase in the number and size of Rab5-positive endosomes, are present in Down's syndrome and AD brains [9] . Importantly, inhibition of both CME in vivo in APP transgenic mice and dynamindependent endocytosis in vitro lowered Aβ levels [10, 11] , whereas up-regulation of endocytosis increased APP metabolism to sAPPβ and βCTF and increased Aβ secretion [7] .
Lipid rafts in the plasma membrane are also important for modulating Aβ production [12, 13] . Caveolae are a type of lipid raft enriched with caveolins-1-3 and are associated with processes including clathrin-independent endocytosis (CIE) [14] . Flotillin-1 and flotillin-2, also found in lipid rafts, noncaveolar lipid raft microdomains in neurones that may also be implicated in endocytosis [15, 16] . Alterations in caveolins have been associated with AD as the expression of caveolin-1 is elevated in the hippocampus in AD compared with non-AD brains [17] .
We have previously considered the importance of changes in endocytosis with ageing for AD pathophysiology by examining the expression of several CME-related and CIE-related endocytic proteins in the cortex of aged transgenic (Tg) Tg2576 mice expressing the Swedish mutation of human APP at the β-secretase cleavage site [18] . Using 22-month-old male mice, we found significantly higher levels of clathrin heavy chain (CHC), dynamin II and PICALM compared with wild-type (WT) mice, but no changes in proteins involved in CIE [18] . However, we did not compare different ages. Therefore, we have now investigated how ageing and the presence of amyloid pathology affect the expression of a range of proteins involved in CME and CIE. We have used the London V717I mouse, a well-characterized model of amyloid pathology that overexpresses human APP 695 with a mutation at V717I [19] . In contrast to our earlier data from the Tg2576 mouse [18] , we did not see any changes in clathrin expression with age or between genotypes, but we did identify an increase in the expression of caveolin-1 with age in WT and Tg mice. Furthermore, interestingly we saw an increase in the expression of an isoform of PICALM in WT mice, but a decrease in Tg mice with age.
Materials and methods

Materials
All chemicals and reagents were purchased from SigmaAldrich (Poole, UK) or Fisher Scientific (Leicester, UK) unless specified. Antibodies used in Western blotting were as follows: anti-N-APP, 22C11 (Millipore, Watford, UK); anti-CHC(Clone 23), anti-caveolin-1, anti-caveolin-2 (Clone 65), anti-flotillin-1 (Clone 18) (BD Biosciences, Oxford, UK); anti-GAPDH (Sigma-Aldrich); anti-BIN-1 (Santa Cruz, Wembley, UK); anti-PICALM, anti-flotillin-2 (Novus Biologicals, Littleton, Colorado, USA); antidynamin-1 (Abcam, Cambridge, Massachusetts, USA).
Mice
Tg mice carrying the London V717I mutation in human APP [19] were maintained on the in-bred C57Bl/6 background. All work described here complied with the guidelines for the care and use of laboratory animals according to the Animals (Scientific Procedures) Act 1986 and in accordance with Home Office (UK) regulations and European Union directive 2010/63/EU.
Protein extraction
Soluble and insoluble proteins were extracted from the total cortices of male 3-, 9-and 18-month-old London Tg mice and WT aged-matched littermates following the method of Rees et al. [18, 20] . Total protein concentration was determined with the BCA Protein Assay Kit (Thermo Scientific, Waltham, Massachusetts, USA).
Western blotting
Western Blotting was performed using standard methods. Briefly, after protein analysis, 10 µg of all samples were resolved on 10% polyacrylamide gels, and detected with the relevant antibody as previously described [18] .
ELISA
Soluble and insoluble human Aβ40 and 42 were detected by enzyme-linked immunosorbent assay (ELISA) as previously described [18] .
Statistical analyses
The Western blot shown for each protein was quantified using Image J (www.imagej.nih.gov). All protein bands were expressed as the relative density of WT cortex sample 1 and then normalized for relative GAPDH levels. ELISA data were expressed as ng Aβ/mg total protein. The blotting data were analyzed by one-way analysis of variance followed by Tukey's post-hoc tests or by unpaired Student's t-tests to determine if protein levels differed significantly between ages or between Tg-matched and age-matched WT mice, respectively. ELISA data were analyzed using Kruskal-Wallis followed by Dunn's multiple comparison test (soluble Aβ) or one-way ANOVA followed by Fisher's LSD test (insoluble Aβ40). Where necessary, data were transformed to fit the assumptions of normality.
Results
Expression of APP, Aβ40 and Aβ42 in the Tg and WT mice
As expected the expression of APP was significantly increased by about three-fold in the cortex of 18-month Tg mice compared with WT mice (P < 0.05) (Fig. 1a) . The levels of APP were not altered by ageing in either WT or Tg mice (Supplementary Figure, Supplemental digital content 1, http://links.lww.com/WNR/A435). Soluble and insoluble Aβ40 and soluble Aβ42 levels from the overexpressed human APP were all significantly increased in 18-month Tg mice compared with younger mice (P < 0.05) (Fig. 2a and b) . Isoform (2) Isoforms (1&3) Isoform (2) (month)
Isoform (2) 18-month 9-month 3-month 18-month 9-month
Comparison of APP, clathrin heavy chain, and three bands for PICALM in the cortex of male wild type (WT) and transgenic (Tg) mice aged 3, 9 and 18 months. Each section shows an immunoblot and densitometric analysis of the immunoblot. (a) Comparison of amyloid precursor protein (APP) expression in 18-month WT and Tg mice; comparison of clathrin expression in (b) WT mice and (c) Tg mice aged 3, 9 and 18 months; comparison of PICALM bands 1, 2 and 3 between (d) 18-month WT and Tg mice, in (e) WT mice and (f) Tg mice aged 3, 9 and 18 months. Levels of APP were significantly increased in 18-month Tg mice compared with WT mice. PICALM band 3 expression was significantly decreased in 18-month Tg mice compared with WT mice and in 18-month Tg mice compared with 3-and 9-month Tg mice, but was increased in 18-month WT mice compared with 3-and 9-month WT mice. Data are represented as mean SEM. *P < 0.05, one-way analysis of variance followed by Tukey's post-hoc tests or unpaired Student's t-tests. n = 3-4 mice for each age group.
Altered endocytic
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Levels of proteins involved in CME are altered by ageing and APP genotype No significant differences in the levels of CHC with increasing age were detected in either WT or Tg mice (Fig. 1b and c) . In contrast, when the level of clathrin was compared between WT and Tg mice brains, a significant decrease was seen in 9-month Tg mice, 0.3 0.02 compared with 0.8 0.1 in WT mice (P < 0.001, optical density ratio relative to GAPDH). There were no significant changes in the levels of clathrin between WT and Tg 18-month WT and Tg mice; soluble and insoluble Aβ40 was significantly increased in 18-month Tg mice compared with 3-and 9-month mice whereas soluble Aβ42 was significantly increased in 18-month Tg mice compared with 9-month mice. Levels of caveolin-1 were significantly increased in 9-and 18-month WT and Tg mice compared with the corresponding 3-month mice. Caveolin-1 expression was significantly decreased in 18-month Tg mice compared with WT mice. Data are represented as mean SEM. *P < 0.05, **P < 0.01, ELISAs Kruskal-Wallis followed by Dunn's multiple comparisons test (soluble Aβ) or one-way analysis of variance (ANOVA) followed by Fisher's LSD test (insoluble Aβ40); Western blots one-way ANOVA followed by Tukey's post-hoc tests or unpaired Student's t-tests. n = 3-4 mice for each age group. At least six isoforms of Mus musculus PICALM have been found with predicted molecular masses ranging from~64 to 72 kDa (NCBI RefSeq). We identified PICALM as three distinct bands at 72, 68 and 62 kDa (Fig. 1d-f) . The largest bands (bands 1 and 2) were analyzed together as they were not fully resolved. There was no detectable change in the levels of bands 1 and 2 with ageing in either WT or Tg mice ( Fig. 1e and f ). There were also no changes in the expression of bands 1 and 2 between WT and Tg mice aged 3, 9 and 18 months (Fig. 1d , Supplementary Table, Supplemental digital content 2, http://links.lww.com/WNR/A436). However, expression of the smallest band of PICALM (band 3) was significantly increased in 18-month WT mice compared with 9-month mice (Fig. 1e) , but was significantly decreased in 18-month Tg mice compared with 3-month mice (Fig. 1f) . Furthermore, the levels of band 3 were significantly reduced by approximately six times in 18-month Tg mice when compared with WT mice (Fig. 1d) . In contrast, there were no changes in the expression of band 3 between WT and Tg mice aged 3 and 9 months (Supplementary Table, The levels of caveolin-1 were significantly higher in both 9-and 18-month WT and Tg mice compared with 3-month mice (Fig. 2a and b) . However, the levels of caveolin-1 were not altered between 3-and 9-month-old WT and Tg mice (Supplementary Table, Supplemental digital content 2, http://links.lww.com/WNR/A436), but were significantly decreased by~1.4 times in 18-month Tg compared with the WT mice (Fig. 2c) . 
mice aged 3 and 18 months (Supplementary
Discussion
The results presented here show that both ageing and genotype affected the expression of endocytic proteins in the cortex of WT and Tg V717I London mutation mice. First, the data obtained for APP expression confirmed that the Tg London mutation mice overexpressed APP compared with the WT mice and second, the data no change in APP expression with age, as expected from other studies [21] . This overexpression of APP led to the expected increase in human Aβ40 and Aβ42 in the 18-month Tg mice.
Interestingly, although there is much evidence, reviewed above, to show that CME is affected in AD and implicated in the pathogenesis of the disease, we saw limited changes in clathrin itself with a decrease only in the 9-month Tg mice compared with the WT mice. We know that cognitive deficits start to appear around 6-9 months of age in these mice that could be linked to the change in clathrin seen here (Hvoslef-Eide, unpublished data). Interestingly, the decrease in clathrin precedes the increase in Aβ in these mice; therefore, a small change in endocytosis in earlier life might be linked to the subsequent rise in Aβ levels in these mice. However, in the cortex of the London mutation mice neither age nor the presence of amyloid pathology appeared to have a large effect on CME as determined by the expression levels of clathrin. Support is provided for this conclusion by the data for dynamin-1, PICALM bands 1 and 2 and Bin-1 where no changes in expression were seen. This is particularly important for dynamin-1, which is crucial for not only CME but also for many forms of CIE to occur. The data for band 3 for PICALM, however, do not fit with this conclusion as its expression was differentially affected by both age and genotype. Currently, the function of the different PICALM isoforms is not understood and we have previously shown that at least human isoforms 1 and 2 are required for PICALM to affect functional endocytosis in the H4 cell line [22] . The most likely explanation for these findings lies in another role of PICALM, in addition to its involvement in CME. More specifically, PICALM controls the endocytosis of R-SNAREs (soluble NSF attachment protein receptors) necessary for the fusion of endocytic vesicles with endosomes or the plasma membrane [23] .
There does appear to be some involvement of ageing and genotype in CIE as the expression of caveolin-1 was increased in both genotypes with age, but to a larger extent Altered endocytic protein expression with age Thomas et al. 967 in the WT mice. Furthermore, this increase in caveolin-1 preceded the increase in Aβ40 and Aβ42 in the Tg mice supporting the data with clathrin and possibly suggesting that changes in endocytosis could be linked to subsequent increases in Aβ accumulation. Another study also found an increase in caveolin-1 with age in WT mice [17] . This is an interesting result as loss of caveolin-1 is associated with accelerated aging and neurodegeneration in mice [24] . These data support those for caveolin-1 expression in the human brain where higher expression was seen in the hippocampus from AD brains compared with non-AD brains [17] . We also detected a significant rise in caveolin-1 expression in human AD frontal cortex compared with age-matched controls (Hvoslef-Eide, unpublished data). Another study found no changes in caveolin-1 in human cortex comparing AD and control individuals [25] , but the effect of age was not considered. The other CIE proteins examined here, caveolin-2, flotillin-1 and flotillin-2 were not affected by ageing or genotype suggesting that any effect of these factors on CIE in mice is not wide-spread.
The results we have obtained here for various endocytic proteins in the V717I London mutation mice contrast with those we obtained for the same proteins in old Tg2576 mice [18] . One possible explanation for these differences lies in the different mutations affecting the β-secretase (Tg2575) and γ-secretase (V717I) cleavage sites in APP leading to higher levels of APP and 10 to over 1400-fold increases in Aβ in the Tg2576 mice [18] . In addition, the different genetic backgrounds of the two mice strains probably also affect other proteins and biochemical pathways such as those involved in endocytosis.
Conclusion
We have shown that proteins involved in both CME and CIE are affected by ageing and also by the presence of amyloid pathology in mice. Our data provide support for the idea that changes in endocytosis are involved in the pathogenesis of AD.
